Appropriate Use Criteria for Hepatobiliary Scintigraphy in Abdominal Pain

The new AUC for Hepatobiliary Scintigraphy addresses several clinical scenarios for abdominal pain. To improve utilization and guide providers across specialties to use HIDA, the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Nuclear Medicine (EANM) and the American Gastroenterological Association (AGA) have collaboratively developed criteria for the appropriate use of this imaging technology to aid in the diagnosis of people with abdominal pain.

SNMMI assembled a HIDA Scan Workgroup consisting of experts in the field of nuclear medicine including radiologists, both diagnostic and pediatric, to review the scientific literature and develop consensus recommendations for the clinical use of this technology. The Oregon Health Science University's (OHSU) Evidence-based Practice Center (EPC) conducted a systematic review of existing evidence based on the scope and parameters the HIDA Scan Workgroup put together, which they used to make their recommendations for clinical use.

Click here to view the Appropriate Use Criteria for Hepatobiliary Scintigraphy in Abdominal Pain.

To view the development process, please click the following link: SNMMI AUC Development Process.